CAV1/caveolin 1 enhances aerobic glycolysis in colon cancer cells via activation of SLC2A3/GLUT3 transcription.
about
The sweet trap in tumors: aerobic glycolysis and potential targets for therapyPathophysiological mechanisms of death resistance in colorectal carcinomaCaveolin-1, a stress-related oncotarget, in drug resistanceDecreased miR-106a inhibits glioma cell glucose uptake and proliferation by targeting SLC2A3 in GBM.Identification of AMP-activated protein kinase targets by a consensus sequence search of the proteome.AMPK modulates Hippo pathway activity to regulate energy homeostasis.Advances in glucose metabolism research in colorectal cancerCaveolin-3 plays a critical role in autophagy after ischemia-reperfusion.Differentiation of high-risk stage I and II colon tumors based on evaluation of CAV1 gene expression.Calcium homeostasis and ER stress in control of autophagy in cancer cellsEstablishment of oral squamous cell carcinoma cell line and magnetic bead-based isolation and characterization of its CD90/CD44 subpopulations.The Glycolytic Switch in Tumors: How Many Players Are Involved?Vascular endothelial growth factor receptors 1,3 and caveolin-1 are implicated in colorectal cancer aggressiveness and prognosis--correlations with epidermal growth factor receptor, CD44v6, focal adhesion kinase, and c-Met.Identification of genomic expression differences between right-sided and left-sided colon cancer based on bioinformatics analysis.Autophagic degradation of caveolin-1 promotes liver sinusoidal endothelial cells defenestration.
P2860
Q26766079-016AC943-3769-4847-A948-CAEFE01BF2B6Q26778007-55BEF03F-B9D2-4AB8-BE4A-59B4DA7A7888Q26782615-ED2B592F-A5A6-454E-BA01-C4957951A0ECQ35017237-1DE93CE6-B73F-46F7-826A-23AB1B1B36CCQ35169812-B2D016E0-B0DE-45BD-A416-2A4833B46F34Q35236353-FA748017-3F89-487C-A295-47D8D978FE19Q37204593-A500CAAA-3D5F-4B2E-84E1-AADF4C5C9793Q38739373-AE634D2D-B549-4FB7-8BB3-6C59A06A3E31Q41505852-5844CFF3-A7AB-4452-8BAE-447C61C756C5Q41951413-DB66C895-E7A5-496B-8E36-74BADC1DC38BQ42371627-55A5DCBA-A77D-4954-BF44-7BC25E5F005BQ45419184-BD082C8C-5408-4293-BEFE-608061F06028Q45570735-03E9BF97-0D96-46F5-8486-16C39264B7D7Q49885724-645F0234-E9C8-45E6-86A6-B991F9441FFDQ55260997-097AD9B2-2532-4AAD-989F-78E5DE6DD9A6
P2860
CAV1/caveolin 1 enhances aerobic glycolysis in colon cancer cells via activation of SLC2A3/GLUT3 transcription.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
CAV1/caveolin 1 enhances aerob ...... of SLC2A3/GLUT3 transcription.
@ast
CAV1/caveolin 1 enhances aerob ...... of SLC2A3/GLUT3 transcription.
@en
type
label
CAV1/caveolin 1 enhances aerob ...... of SLC2A3/GLUT3 transcription.
@ast
CAV1/caveolin 1 enhances aerob ...... of SLC2A3/GLUT3 transcription.
@en
prefLabel
CAV1/caveolin 1 enhances aerob ...... of SLC2A3/GLUT3 transcription.
@ast
CAV1/caveolin 1 enhances aerob ...... of SLC2A3/GLUT3 transcription.
@en
P356
P1433
P1476
CAV1/caveolin 1 enhances aerob ...... of SLC2A3/GLUT3 transcription.
@en
P2093
Sung-Gil Chi
Tae-Kyu Ha
P304
P356
10.4161/AUTO.21487
P577
2012-08-09T00:00:00Z